Note: Ingredients listed on restricted chemical lists
EC/CAS
203-473-3/107-21-1
Name of the chemical
Ethane-1,2-diol
Concentration
≥30
EC/CAS
200-578-6/64-17-5
Name of the chemical
Ethanol
Concentration
≥10
General Information
Version
1.0
Revision date
2023-04-17
Product name
ALPHA LINE Enteiser Eco Series
supplier name
Mibelle AG
Manufacturer Name
Mibelle AG
Emergency telephone
+41 44 251, +41 44 8032
Icons in SDS
Company Information
company name
Mibelle AG
e-mail address of the competent person responsible for the Safety Data Sheet
info@alphaline.ch
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H319, H373
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Adverse physicochemical, human health and environmental effects
May cause damage to organs through prolonged or repeated exposure. Harmful if swallowed. Causes serious eye irritation.
2.2 Label elements
Labelling
Hazard pictograms
GHS07 GHS08
Signal word
Warning
Contains
GLYCOL
Hazard statements
H302 - Harmful if swallowed. H319 - Causes serious eye irritation. H373 - May cause damage to organs (heart, kidneys, lungs) through prolonged or repeated exposure (if swallowed).
Precautionary statements
P102 - Keep out of reach of children. P270 - Do not eat, drink or smoke when using this product. P280 - Wear protective gloves, eye protection/face protection. P305+P351+P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P264 - Wash hands thoroughly after handling. P314 - Get medical advice/attention if you feel unwell. P101 - If medical advice is needed, have product container or label at hand. P501 - Dispose of contents/container to an approved waste disposal plant.
2.3 Other hazards
Contains no PBT/vPvB substances ≥ 0.1% assessed in accordance with REACH Annex XIII The mixture does not contain substance(s) included in the list established in accordance with Article 59(1) of REACH for having endocrine disrupting properties, or is not identified as having endocrine disrupting properties in accordance with the criteria set out in Commission Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at a concentration equal to or greater than 0,1 %